Congo Ebola Outbreak Reaches 7,258 Cases And 3,510 Deaths As Officials See Signs Of Progress
Congo Battles Deadly Ebola Epidemic
Ten Health Zones Have Gone More Than Three Weeks Without A New Case While Transmission Continues Elsewhere.
The Ebola outbreak spreading through the Democratic Republic of the Congo has reached 7,258 confirmed cases and 3,510 deaths, according to government figures published on Tuesday, 15 September 2026. The epidemic now stretches across seven provinces and remains the second deadliest Ebola outbreak ever recorded.
There are, however, early indications that the relentless rise in infections may be beginning to slow in some of the worst-affected areas. Daily new cases have fallen from approximately 120 at the mid-August peak to around 80, while ten of the 62 affected health zones have reported no new cases for more than 22 days. World Health Organization officials are warning that it is still too early to conclude that the outbreak has passed its peak.
The Numbers Show The Extraordinary Scale Of The Outbreak
The latest government tally represents another grim milestone in an epidemic that has expanded dramatically since it was first identified in May.
As of 13 September, Congo had recorded 7,258 confirmed infections, 3,510 deaths and 1,726 recoveries, according to government figures subsequently reported on 15 September. That gives the confirmed cases a fatality ratio of roughly 48.4%.
The outbreak has already surpassed every previous Ebola epidemic recorded inside the Democratic Republic of the Congo.
Only the catastrophic 2014–2016 West African Ebola epidemic, which killed more than 11,000 people across Guinea, Liberia and Sierra Leone, has caused more deaths globally.
That makes the current outbreak historically significant even before its final trajectory is known.
What Is Causing The Congo Ebola Outbreak?
This epidemic is being caused by the Bundibugyo species of Ebola virus, rather than the Zaire species responsible for several of the most familiar previous outbreaks.
Bundibugyo virus disease can cause severe illness involving fever, weakness, gastrointestinal symptoms and, in some patients, bleeding and organ dysfunction.
Transmission occurs through direct contact with the blood or other bodily fluids of an infected person, contaminated materials, or the body of someone who has died from the disease.
The virus does not spread through ordinary airborne transmission in the way influenza or measles does, making rapid diagnosis, isolation, contact tracing, safe healthcare practices and safe burials central to containing an outbreak.
The Epidemic Has Spread Across Eastern Congo
The geographical expansion has been one of the most difficult aspects of the response.
WHO reported on 10 September that confirmed infections had reached 61 health zones across six provinces, with Ituri remaining the principal epicentre and North Kivu becoming the second most affected province. Government figures reported five days later put the outbreak across seven provinces and 62 affected health zones, illustrating how quickly the epidemiological picture continues to change.
Ituri has carried the overwhelming burden of the outbreak from its earliest stages.
WHO's detailed 7 September assessment recorded 5,406 confirmed cases in Ituri alone. North Kivu had already recorded more than 1,000 infections and an unusually high fatality ratio.
The continuing spread matters because every newly affected area increases the number of communities that require surveillance teams, laboratory capacity, treatment facilities, protective equipment, contact tracing and community engagement.
There Are Finally Some Signs Of Progress
The latest update is not uniformly bleak.
Congo's Health Minister Samuel Roger Kamba said the response was showing “encouraging signs” following the apparent infection peak in mid-August.
Daily new confirmed cases have fallen from around 120 during the peak to approximately 80, according to figures cited by Reuters. Ten of the country's 62 affected health zones have also gone more than 22 days without recording another case.
Those changes are significant.
An Ebola response begins to gain control when transmission chains are identified quickly enough for exposed contacts to be monitored, symptomatic patients isolated and new infections prevented before they generate further clusters.
But a falling national average can hide sharply different local situations.
North Kivu Is Moving In The Wrong Direction
North Kivu remains one of the most concerning areas.
Reuters reports that 555 new cases were recorded in the province during the previous 21 days, even as conditions began improving elsewhere.
WHO had already described North Kivu as the second most affected province earlier in September and documented a particularly high case fatality ratio there.
The province presents many of the problems that make Ebola containment exceptionally difficult.
Eastern Congo has endured years of armed conflict, large-scale displacement and insecurity. People frequently move between communities, while some areas are difficult or dangerous for health teams to access.
That creates opportunities for infections to move beyond known contact networks before surveillance teams can detect them.
Why WHO Says It Is Too Early To Declare The Peak Over
The improving national figures have understandably raised hopes that the epidemic may finally be approaching a turning point.
WHO is deliberately more cautious.
Asked whether the outbreak had passed its peak, WHO official Olivier le Polain said it was too early to say confidently that this had happened. UN Ebola coordinator Julien Harneis similarly described the epidemic as still massive and deadly, with progress in some areas occurring alongside continued growth elsewhere.
That distinction matters.
A decrease lasting several days does not necessarily mean transmission has been broken.
Hidden infections, delayed laboratory confirmation, incomplete contact tracing or new transmission clusters can quickly reverse an apparent improvement.
Health authorities therefore need sustained declines across multiple incubation periods before they can have confidence that an outbreak is genuinely retreating.
Why This Outbreak Has Been So Difficult To Stop
Congo's Ebola response is taking place inside an extraordinarily difficult humanitarian environment.
WHO estimates that more than 26 million people are experiencing acute food insecurity, while around one million internally displaced people live in Ituri Province alone.
Conflict and displacement can interrupt healthcare, separate families, overwhelm sanitation systems and make reliable contact tracing significantly more difficult.
Some communities are remote. Others experience frequent population movement connected with mining, trade or displacement.
WHO reported in early September that more than 24,000 contacts required follow-up, demonstrating the extraordinary operational scale of the response.
Every missed contact can potentially become the beginning of another transmission chain.
The Vaccine Problem Is Different This Time
Vaccines have transformed the world's ability to control outbreaks caused by the Zaire Ebola virus.
The situation with Bundibugyo Ebola is more complicated.
Ervebo, the licensed Ebola vaccine used against Zaire ebolavirus, has not been proven to protect humans against Bundibugyo virus disease.
WHO's Strategic Advisory Group of Experts concluded in August that the available evidence was insufficient to recommend routine use of Ervebo against Bundibugyo Ebola. It therefore recommends its use in this outbreak only within a research protocol.
Vaccination of healthcare and frontline workers under that research framework has already begun.
By 6 September, WHO reported that 2,007 people had been vaccinated across six health zones in three provinces.
That research could ultimately provide crucial evidence about whether an existing vaccine can offer useful protection against the strain driving the current epidemic.
Researchers Are Also Testing Treatments
There is likewise no established Bundibugyo-specific treatment capable of simply curing the disease.
High-quality supportive care remains critical. Rapid access to fluids, treatment of complications and careful clinical management can substantially affect a patient's chances of survival.
Researchers are also trying to improve the available options.
WHO says the PARTNERS clinical trial began enrolling confirmed Bundibugyo Ebola patients in July and has expanded to multiple treatment facilities in Ituri. More than 300 people had entered the trial by early September.
The results could help determine which therapeutic approaches are most effective during future Bundibugyo outbreaks as well as the current emergency.
The Threat Does Not Stop At Congo's Borders
The outbreak has already demonstrated its ability to cross national borders.
Cases linked to the epidemic have been recorded in Uganda, while patients diagnosed after exposure in Congo have also received treatment outside the country.
Uganda recorded 20 confirmed cases and two deaths before bringing its transmission chain under control. A case was also diagnosed in France, while two patients originally confirmed in Congo were treated in Germany.
WHO says enhanced screening and surveillance remain active at airports, ports and official land crossings.
The greater challenge is informal movement across borders, particularly in regions where communities, families and commercial networks extend across national boundaries.
That is why neighbouring countries cannot simply wait to see whether Congo succeeds.
Preparedness, laboratory capacity, rapid testing, contact tracing and healthcare-worker protection remain essential throughout the region.
The Next Few Weeks Could Be Decisive
There is now a genuine tension at the heart of Congo's Ebola outbreak.
The raw numbers remain devastating: 7,258 confirmed cases and 3,510 deaths.
Yet the latest trajectory also contains the clearest signals of improvement seen during the epidemic.
Daily infections are lower than they were at the mid-August peak. Several health zones have gone weeks without detecting another case. Response teams appear to be gaining ground in parts of Ituri.
At the same time, North Kivu continues to record large numbers of infections, the epidemic has spread across seven provinces and thousands of contacts still require monitoring.
That is why the next stage matters so much.
If declining transmission can be sustained and replicated in the hardest-hit areas, September could eventually be remembered as the moment Congo began to turn the epidemic around.
If new transmission chains accelerate in North Kivu or other vulnerable regions, the apparent progress could prove temporary.
For now, the most accurate description is neither victory nor uncontrolled collapse.
Congo may finally be bending the Ebola curve — but an outbreak that has already killed more than 3,500 people remains far from over.
